progscrape: nejm.org

Microvascular Injury in the Brains of Patients with Covid-19

3 years ago nejm.org covid

Results from the primary analysis of the ongoing phase 3 clinical trial of US biotechnology company Moderna's Covid-19 vaccine have revealed 94.1 per cent efficacy of the therapeutic in preventing symptomatic infections and severe illness…

3 years ago nejm.org covid trial vaccine

Gene editing ostensibly cures sickle cell anemia in a patient for the first time.

3 years ago nejm.org

CRISPR-Cas9 gene editing successful for a patient with Sickle Cell Disease and another patient with transfusion dependent β-Thalassemia - More than a year later, both patients had clinically improved and no longer needed blood transfusions

3 years ago nejm.org disease

Remdesivir, hydroxychloroquine, lopinavir, and interferon regimens had little or no effect on hospitalized patients with Covid-19, as indicated by overall mortality, initiation of ventilation…

3 years ago nejm.org covid

How a COVID-19 outbreak was rapidly controlled without a lockdown. On October 11, 2020, 3 cases were reported in Qingdao, China

4 years ago nejm.org china covid

An outbreak of COVID-19 occurred on the USS Theodore Roosevelt, a nuclear-powered aircraft carrier with a crew of 4,779

4 years ago nejm.org covid

Dying in a Leadership Vacuum

4 years ago nejm.org

New England Journal of Medicine Resoundingly Endorses Biden

4 years ago nejm.org biden

Genetic Risk of Severe Covid-19

4 years ago nejm.org covid genetics